AOD-9604 has undergone extensive preclinical and clinical research, including multiple Phase II human trials demonstrating its safety and efficacy for body composition improvement
Available from: Rogol AD, Hayden GF
Notably, the weight loss was not driven by appetite suppression, distinguishing 5-Amino-1MQ from GLP-1 agonists and other appetite-modulating compounds
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
Product Details Product Name: 5-Amino-1MQ 50mg Form: Lyophilized powder Purity: 99% (HPLC verified) Packaging: Sterile sealed vial Storage: Store in a cool, dry place Intended Use: For laboratory research use only Notice: This material is supplied strictly for research purposes only
Have been coming here for weight loss